AzTrials
AzTrials

Outcome StudiesEPOKNCT05456217

Epidemiological Characteristics and Outcomes of Patients Admitted to Kenyan Critical Care Units (EPOK).

An observational study of Outcome Studies and Mechanical Ventilation, run by Nat Intensive Care Surveillance - MORU at 6 sites in Kenya.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The Kenyan Critical Care Registry was started in December 2020 and currently involves 10 critical care units in 6 Hospitals. As an initial registry output, we aim to describe patient epidemiological characteristics, initial management and outcomes of critically ill patients in Kenya. Read more about this study

Who is it for?
Any age
Conditions the study is for
Outcome Studies, Mechanical Ventilation, Kenya
What is being tested?
admission to ICU
How many people
4,000 participants
Where
6 sitesKenya
Study dates
1 Jan 2021to 1 Sep 2022
How long will I take part?
4 Weeks
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Child, Adult, Older adult

Study population: Consecutive patients admitted to ICUs or HDUs participating in the Kenya Critical Care registry

Who may be able to join

  • Admitted to an intensive care unit or high dependency unit
  • Included in the Kenya Critical Care registry platform

Who cannot join

  • None

Trial locations and contacts

6 sites in 1 country.

Wangari Siika, Prof. contact

+254 708 612258

wangari.siika@aku.edu

Carolyne Njoki, Dr contact

+254 720 562416

njokimuiru@gmail.com

6 sites in 1 country

Kenya6 sites, 6 recruiting
  • Kisii County Hospital

    Kisii

    Nabukwangwa Simiyu, MD, nabukwangwas@gmail.com

    Annastacia Kioko, annexiekioko56@gmail.com

    Recruiting
  • Mombasa Aga Khan Hospital

    Mombasa

    Ronnie Kaddu, MD, ronnie.kaddu@akhskenya.org

    Selina Mutuku, selina.mutuku@akhskenya.org

    Recruiting
  • Aga Khan University Hospital

    Nairobi

    Wangari Siika, Prof.

    Teddy Thaddeus, RN, teddythaddeus102@gmail.com

    Recruiting
  • MP Shah Hospital

    Nairobi

    Vishal Patel, vpatel@mpshahhospital.org

    Thomas Kabanya, tommkabanya2@gmail.com

    Recruiting
  • Nakuru level V Hospital

    Nakuru

    Carolyne Njoki, MD, Njokimuiru@gmail.com

    Patricia Wangeci, janelpatricia5@gmail.com

    Recruiting
  • Nyeri County Hospital

    Nyeri

    Wambui Mwangi, MD, o.wamwangi@gmail.com

    Peter Mburu, pitkama12@gmail.com

    Recruiting

Other trials in Kenya

About this study

Official title: Clinical Characteristics and Outcomes of Patients Admitted to Kenyan Critical Care Units During the COVID-19 Pandemic: a Multicenter Registry-based Observational Study

The Kenyan Critical Care Registry was started in December 2020 and currently involves 10 critical care units in 6 Hospitals. As an initial registry output, we aim to describe patient epidemiological characteristics, initial management and outcomes of critically ill patients in Kenya. This project will provide a much-needed source of clinico-demographic and outcomes data for participating Kenyan critical care units. It will also help to identify processes and outcomes which can be targeted by quality improvement projects, the impact of which can then be evaluated later using the registry.

Read the detailed description

Background:

The burden of critically ill patients is growing in low and middle income countries (LMICs), but the resources available to assist these patients are limited.1 Critical care is an established and rapidly evolving service in Kenya.2 Yet, patient epidemiological characteristics, patterns of ICU management and patient outcomes in Kenyan ICUs remain scarcely investigated.3,6,7

The ICU registry:

The Kenyan Critical Care Registry was started in December 2020 after receiving ethical approval in November 2020, and currently involves 10 units in 6 Hospitals. The registry was launched in collaboration with the Network for Intensive Care Systems and Training (NICST) and the Mahidol Oxford Research Unit (MORU). As in other countries, the Kenyan Critical Care registry aims to play an increasingly pivotal role in evaluating treatment outcomes, benchmarking services and providing opportunities for service forecasting. Dedicated data collectors in each registry site perform real-time data collection. All registry data is housed and stored securely on a national server located on Kenyan soil. Once entered electronically on password-protected computers at participating facilities, it is automatically encrypted before it leaves the institution for the visualization loop within a ring-fenced server at NICST, where it is unencrypted and aggregated for automated visualization. NICST follows healthcare standard GDP and HIPAA standards. The processed data is then re-encrypted before it is transferred back to the national server, where it is automatically unencrypted and available for review by authorized personnel, through a secure two step log in - a process that is navigated with the help of Kenyan IT teams. An audit trail is created any time the registry is accessed, to see who has logged into it, when, and what data was retrieved or modified.

Study aims:

In this study we aim to describe patient epidemiological characteristics, basic management and outcomes of critically ill patients in Kenya during and after the COVID-19 pandemic, leveraging on the newly-implemented Kenya Critical Care Registry housed under the Critical Care Society of Kenya (CCSK). Study outcomes include clinico-demographic characteristics of patients admitted to critical care units within the Kenya Critical Care Registry network, primary management process measures and short-term critical care outcomes.

Patients:

All patients admitted to participating critical care units from the day of registry onset to the day of database analysis will be included. A secure, non-proprietary, real-time, cloud-based platform designed by NICST, adapted for use at participating facilities when the registry began, is used for data entry and management. A critical care minimum dataset (CCMDS) of variables was employed by the investigators, in consultation with the critical care team at participating facilities.

Ethical Considerations:

Ethical clearance from the Aga Khan University Institutional Ethics Review Committee (IERC) to begin registry creation was obtained in November 2020 (Ref:2019/IERC-89) and a NACOSTI licence secured. Site approvals from NACOSTI-accredited ethical committees and/or administrative clearance were obtained from participating institutions prior to commencement. Ethical/administrative and national regulatory approvals for this present study will be sought in the same manner, prior to study commencement.

Benefits:

There will not be any direct benefit to patients at the outset. The expected improvement in critical care processes and outcomes enabled by the registry data analysis will have the potential to directly benefit future critically ill patients in Kenya. In addition the information gathered on admission, patient flow, occupancy and acuity will be essential to helping Kenyan administrative and management team plan future critical care resource provision, optimising critical care resource utilisation and cost effectiveness. The study may also provide important context specific COVID-19 case-mix and outcome data that may be of value to clinicians, administrators and policy makers during the ongoing pandemic.

Confidentiality:

Access to the electronic registry will be restricted to personnel authorized by the leadership at participating facilities, each of whom have been provided with a unique login and password for this purpose. Each person with such access to the registry has signed a data protection agreement, indicating that they will not share their login details with anyone else, and that they will not share the contents of the registry with unauthorized personnel.

As in other ICU registries, identifiable patient data is restricted to hospital staff authorized to access the critical care registry by the administration of individual facilities.The data extraction for analysis will concern only de-identified data.

Being tested
admission to ICU

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • admission to ICUOther

    admission to an intensive care unit or high dependency unit in Kenya

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. ICU mortality

    death during ICU or HDU stay

    Measured: 1 month

  2. Length of ICU stay

    duration of stay in the ICU or HDU in days

    Measured: 1 month

  3. Demographic characteristics

    The following demographic characteristics are collected: age, sex

    Measured: ICU admission

  4. APACHE 2 score

    Acute Physiology and Chronic Evaluation 2 score

    Measured: ICU admission

Secondary outcomes (6)
  1. Patients receiving mechanical ventilation

    Proportion of patients receiving invasive mechanical ventilation in the ICU or HDU

    Measured: 1 month

  2. Tracheostomy rate

    Proportion of patients receiving a tracheostomy in the ICU or HDU

    Measured: 1 month

  3. Reason for admission

    Reason for admission using APACHE IV classification system and SNOMED CT nomenclature

    Measured: ICU admission - first 24h

  4. Use of vasopressors

    Use of vasopressors on ICU admission

    Measured: ICU admission - first 24h

  5. Use of sedatives

    Use of sedative drugs on ICU admission

    Measured: ICU admission - first 24h

  6. Use of antibiotics on ICU admission

    Proportion of patients with at least one antibiotic prescribed on ICU admission

    Measured: ICU admission - first 24h

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jul 2022
  2. Study start1 Jan 2021
  3. Primary completion1 Aug 2022 (estimated)
  4. Study completion1 Sep 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
4,000 participants (estimated)
Target duration
4 Weeks
IDs, dates and publications
ClinicalTrials.gov ID
NCT05456217
Sponsor's protocol ID
CCAA-K-1-22
Acronym
EPOK
Status last verified
Jul 2022
First submitted
11 Jul 2022
Last updated
13 Jul 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Pisani L, Waweru-Siika W, Sendagire C, Beane A, Haniffa R. Critically ill COVID-19 patients in Africa: it is time for quality registry data. Lancet. 2021 Aug 7;398(10299):485-486. doi: 10.1016/S0140-6736(21)01549-X. No abstract available.

    PubMed 34364515
  • Njoki C, Simiyu N, Kaddu R, Mwangi W, Sulemanji D, Oduor P, Dona DG, Otieno D, Abonyo TT, Wangeci P, Kabanya T, Mutuku S, Kioko A, Muthoni J, Kamau PM, Beane A, Haniffa R, Dondorp A, Misango D, Pisani L, Waweru-Siika W. EPidemiology, clinical characteristics and Outcomes of 4546 adult admissions to high-dependency and intensive care units in Kenya (EPOK): a multicentre registry-based observational study. Crit Care Explor. 2024 Feb 1;6(2):e1036. doi: 10.1097/CCE.0000000000001036. eCollection 2024 Feb 1.

    PubMed 38356864

Questions about this trial

What is this clinical trial studying?

An observational study of Outcome Studies and Mechanical Ventilation, run by Nat Intensive Care Surveillance - MORU at 6 sites in Kenya.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in Kenya. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Wangari Siika, Prof. (+254 708 612258, wangari.siika@aku.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

ICU mortality (time frame: 1 month). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05456217, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in